Sleep for attention by attention to sleep

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20912

Enrollment

Registered

2019-02-04

Start date

2019-06-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD in adults Sleep disorders

Interventions

A 12-week intervention of: (1) a protocolled sleep treatment for their sleep disorder

(2) treatment as usual (TAU) for ADHD

or (3) a combined treatment of sleep and TAU.

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: age 18-50 years, diagnosed ADHD (or ADD), understanding of the Dutch language, a positive screening on the HSDQ for at least one of the following sleep disorders: DSPS, RLS / PLMS, sleep-disordered breathing, and/or insomnia.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: comorbid disorders that require immediate treatment, psychotic disorder, mental retardation, pregnancy or active wish to conceive (in females), use of ADHD or sleep medication in the prior month, history of sleep treatment, and any morbidity affecting sleep (e.g. diabetes).

Design outcomes

Primary

Measure	Time frame
The comparison of the reduction on the ADHD-RS between treatment arms	—

Secondary

Measure	Time frame
The comparison of the reduction on the objective ADHD symptoms using the QbTest, and the depressive symptoms using the QIDS between treatment arms. The study will also provide the opportunity to examine the following: a. The baseline EEG characteristics and the hypnograms of the total group of adults with ADHD. b. The evaluation of each treatment arm on the improvement of subjective sleep quality using the PSQI, and also objective sleep using the Actiwatch and home-PSG characteristics (EEG and hypnogram). c. The types and severities of sleep disorders and their indicated treatments in adults with ADHD. d. The effect of TAU on the objective sleep parameters from the Actiwatch and home-PSG	—

Measure

Time frame

The comparison of the reduction on the objective ADHD symptoms using the QbTest, and the depressive symptoms using the QIDS between treatment arms. The study will also provide the opportunity to examine the following: a. The baseline EEG characteristics and the hypnograms of the total group of adults with ADHD. b. The evaluation of each treatment arm on the improvement of subjective sleep quality using the PSQI, and also objective sleep using the Actiwatch and home-PSG characteristics (EEG and hypnogram). c. The types and severities of sleep disorders and their indicated treatments in adults with ADHD. d. The effect of TAU on the objective sleep parameters from the Actiwatch and home-PSG

—

Contacts

Public ContactDenise Bijlenga

PsyQ Expertise Center Adult ADHD

dbijlenga@sein.nl+31-(0)883573076

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)